glp-1 drugs hypothyroidism 10 Surprising Facts About GLP-1/GIP Medications in Hypothyroid Patients Dual Glucagon-Like Peptide-1 (GLP-1) and
Description
2017 Oct 4;8:1765

alternative pain management is often preferred during active weight loss therapy

Clin Cancer Res

Discontinuation of GLP-1 receptor agonists or switching to DPP4i or SGLT2i alone resulted in worsening HbA1c levels at follow-up (by 1.5%, 1.1%, and 1.1%, respectively)

Research in earlier phases or small trials include evaluation of GLP-1s for cystic fibrosis-related diabetes, polycystic ovarian syndrome (PCOS), chronic obstructive pulmonary disease (COPD), Prader-Willi syndrome (PWS), asthma, substance or alcohol use disorder and as add-on to insulin for type 1 diabetes
